KIMBERLY BARILLA: Open Payments
NPI 1346340064 · LEHIGHTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 59 payments from 10 companies in 2025. Trend: 2023 $1,232 · 2024 $1,308 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $363 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $245 |
| E.R. Squibb & Sons, L.L.C. | 8 | $209 |
| Braeburn Inc. | 1 | $96 |
| Alkermes, Inc. | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Indivior Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, COBENFY, BRIXADI, ARISTADA, REXULTI, Jornay PM, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
